Dornach, Switzerland

Herman Kempen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Circomed LLC. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herman Kempen. Retrieved from https://idiyas.com/inventor/herman-kempen-2xt491xr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Herman Kempen: Pioneering Thienotriazolodiazepine Derivatives

Introduction

Herman Kempen, an accomplished inventor based in Dornach, Switzerland, has made significant contributions to the field of pharmaceutical chemistry. With one patent to his name, Kempen's work focuses on the development of thienotriazolodiazepine derivatives, which have important implications for treating serious health conditions.

Latest Patents

Kempen's notable patent involves thienotriazolodiazepine derivatives that exhibit activity on apo A. The invention details new compounds characterized by a specific formula, which includes variations of groups connected to a phenyl ring. These compounds and their pharmaceutically acceptable acid addition salts are highlighted for their utility in treating and preventing atherosclerotic artery diseases, including myocardial infarction and stroke, as well as Alzheimer’s disease. This innovation represents a meaningful step in advancing therapeutic options for complex medical conditions.

Career Highlights

Herman Kempen currently works at Circomed LLC, where he continues to engage in pioneering research and development. His effort in the pharmaceutical sector is driven by a commitment to improving health outcomes through innovative therapeutics. With a focus on the synthesis and application of chemical compounds, Kempen’s work exemplifies the intersection of science and medicine.

Collaborations

Throughout his career, Herman Kempen has collaborated with esteemed colleagues, including Daniel Bellus and Barbara Staehelin. These partnerships have enhanced his research efforts, allowing for a multidisciplinary approach to tackling significant medical challenges. Such collaborations reflect the importance of teamwork in driving innovation in the scientific community.

Conclusion

Herman Kempen's innovative work in creating thienotriazolodiazepine derivatives marks a significant contribution to medical science. His patent not only advances our understanding of pharmaceutical applications but also showcases the vital role of inventors in addressing pressing health concerns. As the field of pharmaceutical chemistry continues to evolve, Kempen's contributions will undoubtedly play a pivotal role in shaping future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…